Preoperative MRSA screening using a simple questionnaire prior elective total joint replacement.
MRSA
Periprosthetic joint infection
Staphylococcus aureus
Surgical site infection
Targeted screening
Universal screening
Journal
Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
received:
04
11
2023
accepted:
02
04
2024
medline:
24
4
2024
pubmed:
24
4
2024
entrez:
23
4
2024
Statut:
aheadofprint
Résumé
The purpose of this study was to evaluate the management and results of our standarized protocol for preoperative identification of MRSA colonisation in patients undergoing primary total hip and knee replacement procedures. Following hospital protocol, between January 2016 and June 2019 37,745 patients awaiting elective joint replacement underwent a standardized questionnaire to assess the risk of MRSA infection, identifying patients requiring preoperative MRSA screening. An evaluation of the questionnaire identified effective questions for identifying infected patients. Furthermore, an analysis evaluated the impact of comorbidities or Charlson Comorbidity Index scores on positive MRSA colonization. Additionally, we evaluated the cost savings of targeted testing compared to testing all surgery patients. Of the 37,745 patients, 8.057 (21.3%) were swabbed, with a total of 65 (0.81%) positive tests. From this group 27 (36.48%) who were treated were negative before surgery. Some of the questionnaire results were consistently associated with a higher chance of colonization, including hospitalization during the past year (47,7%), previous history of MRSA (44,6%), and agriculture or cattle farming related work (15,4%). By selectively testing high-risk patients identified through the questionnaire, we achieved a 79% reduction in costs compared to universal MRSA screening. Our results suggest that the simple and standardized questionnaire is a valuable tool for preoperative screening, effectively identifying high-risk patients prone to MRSA colonisation. The risk of periprosthetic joint infection (PJI) and its associated sequelae may be reduced by this approach.
Identifiants
pubmed: 38653834
doi: 10.1007/s00402-024-05315-4
pii: 10.1007/s00402-024-05315-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Beam E, Osmon D (2018) Prosthetic joint infection update. Infect Dis Clin North Am 32(4):843–859
pubmed: 30241717
doi: 10.1016/j.idc.2018.06.005
Patel R (2023) Periprosthetic Joint Infection. Reply. N Engl J Med 388(15):1439
pubmed: 37043665
doi: 10.1056/NEJMc2302028
Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE et al (2015) Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection. J Arthroplasty 30(9):1492–1497
pubmed: 25865815
doi: 10.1016/j.arth.2015.03.035
Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA (2014) The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty 29(5):929–932
pubmed: 24140271
doi: 10.1016/j.arth.2013.09.017
Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA (2016) Periprosthetic joint infection. Lancet 387(10016):386–394
pubmed: 26135702
doi: 10.1016/S0140-6736(14)61798-0
Whitehouse MR, Parry MC, Konan S, Duncan CP (2016) Deep infection after hip arthroplasty: staying current with change. Bone Joint J 98–B(1 Suppl A):27–30
pubmed: 26733637
doi: 10.1302/0301-620X.98B1.36294
Sloan M, Premkumar A, Sheth NP (2018) Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 100(17):1455–1460
pubmed: 30180053
doi: 10.2106/JBJS.17.01617
Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS (2012) A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg Br 94(5):619–623
pubmed: 22529080
doi: 10.1302/0301-620X.94B5.27073
Premkumar A, Kolin DA, Farley KX, Wilson JM, McLawhorn AS, Cross MB et al (2021) Projected Economic Burden of Periprosthetic Joint Infection of the hip and knee in the United States. J Arthroplasty 36(5):1484–1489e3
pubmed: 33422392
doi: 10.1016/j.arth.2020.12.005
Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ (2002) The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 23(4):183–189
pubmed: 12002232
doi: 10.1086/502033
Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR et al (2017) Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 152(8):784–791
pubmed: 28467526
doi: 10.1001/jamasurg.2017.0904
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466(7):1710–1715
pubmed: 18421542
pmcid: 2505241
doi: 10.1007/s11999-008-0209-4
Tsaras G, Osmon DR, Mabry T, Lahr B, St Sauveur J, Yawn B et al (2012) Incidence, secular trends, and outcomes of prosthetic joint infection: a population-based study, olmsted county, Minnesota, 1969–2007. Infect Control Hosp Epidemiol 33(12):1207–1212
pubmed: 23143357
pmcid: 3602045
doi: 10.1086/668421
Moran GJ, Amii RN, Abrahamian FM, Talan DA (2005) Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11(6):928–930
pubmed: 15963289
pmcid: 3367577
doi: 10.3201/eid1106.040641
Le Vavasseur B, Zeller V (2022) Antibiotic Therapy for Prosthetic Joint Infections: an overview. Antibiot (Basel). ;11(4)
Zeller V, Kerroumi Y, Meyssonnier V, Heym B, Metten MA, Desplaces N et al (2018) Analysis of postoperative and hematogenous prosthetic joint-infection microbiological patterns in a large cohort. J Infect 76(4):328–334
pubmed: 29395369
doi: 10.1016/j.jinf.2017.12.016
National Nosocomial Infections Surveillance S. National Nosocomial Infections Surveillance (NNIS) (2004) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470–485
doi: 10.1016/j.ajic.2004.10.001
Sexton T, Clarke P, O’Neill E, Dillane T, Humphreys H (2006) Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 62(2):187–194
pubmed: 16290319
doi: 10.1016/j.jhin.2005.07.017
Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE et al (2008) Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 197(9):1226–1234
pubmed: 18422434
doi: 10.1086/533494
Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA et al (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5(12):751–762
pubmed: 16310147
doi: 10.1016/S1473-3099(05)70295-4
Albrich WC, Harbarth S (2008) Health-Care workers: source, vector, or victim of MRSA? Lancet Infect Dis 8(5):289–301
pubmed: 18471774
doi: 10.1016/S1473-3099(08)70097-5
Boyce JM (2001) MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 48(Suppl A):S9–14
pubmed: 11759035
doi: 10.1016/S0195-6701(01)90005-2
Hernandez-Porto M, Castro B, Ramos MJ, Arias A, Aguirre-Jaime A, Lecuona M (2014) Risk factors for development of methicillin-resistant Staphylococcus aureus-positive clinical culture in nasal carriers after decolonization treatment. Am J Infect Control 42(7):e75–e79
pubmed: 24855930
doi: 10.1016/j.ajic.2014.03.011
Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W et al (2009) Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 80(4):486–490
pubmed: 19593719
pmcid: 2823191
doi: 10.3109/17453670903110675
Patel A, Calfee RP, Plante M, Fischer SA, Arcand N, Born C (2008) Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. J Bone Joint Surg Br 90(11):1401–1406
pubmed: 18978255
doi: 10.1302/0301-620X.90B11.20771
de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37(5):387–397
pubmed: 19398246
doi: 10.1016/j.ajic.2008.12.010
Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA (2000) Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21(5):319–323
pubmed: 10823564
doi: 10.1086/501763
Troughton R, Birgand G, Johnson AP, Naylor N, Gharbi M, Aylin P et al (2018) Mapping national surveillance of surgical site infections in England: needs and priorities. J Hosp Infect 100(4):378–385
pubmed: 29906490
doi: 10.1016/j.jhin.2018.06.006
Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L et al (2014) Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(S2):S66–S88
pubmed: 25376070
doi: 10.1017/S0899823X00193869
Hasan MM, Kang R, Lee J, Beal MD, Ahmed AG, Tian Y et al (2022) Is there variation in utilization of preoperative tests among patients undergoing total hip and knee replacement in the US, and does it affect outcomes? A population-based analysis. BMC Musculoskelet Disord 23(1):972
pubmed: 36357880
pmcid: 9647906
doi: 10.1186/s12891-022-05945-y
Parvizi J, Shohat N, Gehrke T (2017) Prevention of periprosthetic joint infection: new guidelines. Bone Joint J 99–B(4 Supple B):3–10
pubmed: 28363888
doi: 10.1302/0301-620X.99B4.BJJ-2016-1212.R1
Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR (2008) Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 466(6):1349–1355
pubmed: 18347889
pmcid: 2384050
doi: 10.1007/s11999-008-0210-y
Perl TM (2003) Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 134(5):S10–S7
pubmed: 14647028
doi: 10.1016/S0039-6060(03)00391-X
Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J (2017) Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin. Clin Orthop Relat Research® 475:1767–1774
doi: 10.1007/s11999-017-5302-0
Zanetti G, Giardina R, Platt R (2001) Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis 7(5):828–831
pubmed: 11791504
pmcid: 2631868
doi: 10.3201/eid0705.017509
Norton TD, Skeete F, Dubrovskaya Y, Phillips MS, Bosco JD 3rd, Mehta SA (2014) Orthopedic surgical site infections: analysis of causative bacteria and implications for antibiotic stewardship. Am J Orthop (Belle Mead NJ) 43(5):E89–92
pubmed: 24839634
Singh N, Nair R, Goto M, Carvour ML, Carnahan R, Field EH et al (2019) Risk of recurrent Staphylococcus aureus Prosthetic Joint Infection in Rheumatoid Arthritis Patients-A Nationwide Cohort Study. Open Forum Infect Dis 6(11):ofz451
pubmed: 31737738
pmcid: 6847211
doi: 10.1093/ofid/ofz451
Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461:48–53
pubmed: 17534195
doi: 10.1097/BLO.0b013e3181123d4e
Scherr TD, Hanke ML, Huang O, James DB, Horswill AR, Bayles KW et al (2015) Staphylococcus aureus Biofilms Induce Macrophage Dysfunction through Leukocidin AB and Alpha-Toxin. mBio. ;6(4)
Skråmm I, Moen AEF, Årøen A, Bukholm G (2014) Surgical site infections in orthopaedic surgery demonstrate clones similar to those in orthopaedic Staphylococcus aureus nasal carriers. JBJS 96(11):882–888
doi: 10.2106/JBJS.M.00919
Goyal N, Miller A, Tripathi M, Parvizi J (2013) Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 95–B(1):4–9
pubmed: 23307666
doi: 10.1302/0301-620X.95B1.27973
Baratz MD, Hallmark R, Odum SM, Springer BD (2015) 20% of patients may remain colonized with methicillin-resistant Staphylococcus aureus despite a decolonization protocol in patients undergoing Elective Total Joint Arthroplasty. Clin Orthop Relat Res 473(7):2283–2290
pubmed: 25690169
pmcid: 4457751
doi: 10.1007/s11999-015-4191-3
Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D et al (2010) Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 92(9):1820–1826
pubmed: 20610773
doi: 10.2106/JBJS.I.01050
Sai N, Laurent C, Strale H, Denis O, Byl B (2015) Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice. Antimicrob Resist Infect Control 4:56
pubmed: 26688720
pmcid: 4683972
doi: 10.1186/s13756-015-0096-x
Bellini C, Petignat C, Masserey E, Bula C, Burnand B, Rousson V et al (2015) Universal screening and decolonization for control of MRSA in nursing homes: a cluster randomized controlled study. Infect Control Hosp Epidemiol 36(4):401–408
pubmed: 25782894
doi: 10.1017/ice.2014.74
Suratwala S, Kommareddy D, Duvvuri P, Woltmann J, Segal A, Krauss E (2023) Cost-effectiveness and clinical utility of universal pre-admission MRSA screening in total joint arthroplasty patients. J Hosp Infect 138:27–33
pubmed: 37277014
doi: 10.1016/j.jhin.2023.05.012
Hays MR, Kildow BJ, Hartman CW, Lyden ER, Springer BD, Fehring TK et al (2023) Increased incidence of Methicillin-Resistant Staphylococcus aureus in knee and hip prosthetic joint infection. J Arthroplasty 38(6S):S326–S30
pubmed: 36813212
doi: 10.1016/j.arth.2023.02.025
Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R (2008) Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 61(1):26–38
pubmed: 17986491
doi: 10.1093/jac/dkm416
Vestergaard M, Frees D, Ingmer H (2019) Antibiotic resistance and the MRSA Problem. Microbiol Spectr. ;7(2)
Lee S, Park YJ, Oh EJ, Kahng J, Yoo JH, Jeong IH et al (2007) Comparison of protocols for surveillance of methicillin-resistant Staphylococcus aureus (MRSA): medical staff vs ICU patients. Ann Clin Lab Sci 37(3):248–250
pubmed: 17709688